Skip to Content

Hizentra Prices, Coupons and Patient Assistance Programs

Hizentra (immune globulin subcutaneous) is a member of the immune globulins drug class and is commonly used for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Primary Immunodeficiency Syndrome.

Hizentra Prices

This Hizentra price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Hizentra subcutaneous solution 20% is around $188 for a supply of 5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Subcutaneous Solution

20% Hizentra subcutaneous solution
from $187.55 for 5 milliliters
Quantity Per unit Price
5 milliliters $37.51 $187.55
10 milliliters $36.66 $366.59
20 milliliters $36.23 $724.68
50 milliliters $35.98 $1,798.96

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Hizentra Coupons and Rebates

Hizentra offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Patient Assistance Programs for Hizentra

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: CSL Behring IgIQ Program

Elligibility requirements:

  1. Must be uninsured or underinsured
  2. Not disclosed
  3. FDA-approved diagnosis
  4. The patient must be a US citizen or legal resident.
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.

Applicable drugs:

  • Hizentra (immune globulin-subcutaneous) Vial; Single-Use 20%
Hide